NCT07399730

Ravulizumab Outcomes in Polish Patients With aHUS

RecruitingOBSERVATIONAL

Trial Details

Start: 2026-06-24Est. Completion: 2029-09-30

Enrollment target: 80 participants

Locations

Contact

AstraZeneca Clinical Study Information Center Study Information Centerinformation.center@astrazeneca.com +118772409479

Atypical Hemolytic Uremic Syndrome

This study aims to evaluate the efficacy and safety of crovalimab in pediatric participants with aHUS.

Aurora, United StatesEst. completion Jul 4, 2025

Atypical Hemolytic Uremic Syndrome

Atypical hemolytic uremic syndrome (aHUS) is a rare, progressive, and life-threatening disease that occurs at any age, w…

Alexandria, EgyptCompleted Apr 6, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.